Does ADO-TRASTUZUMAB EMTANSINE Cause Hepatic function abnormal? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Hepatic function abnormal have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 0.9% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.
75
Reports of Hepatic function abnormal with ADO-TRASTUZUMAB EMTANSINE
0.9%
of all ADO-TRASTUZUMAB EMTANSINE reports
4
Deaths
30
Hospitalizations
How Dangerous Is Hepatic function abnormal From ADO-TRASTUZUMAB EMTANSINE?
Of the 75 reports, 4 (5.3%) resulted in death, 30 (40.0%) required hospitalization, and 2 (2.7%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?
Nausea (780)
Fatigue (774)
Disease progression (750)
Diarrhoea (654)
Off label use (630)
Thrombocytopenia (519)
Death (509)
Neuropathy peripheral (506)
Headache (465)
Platelet count decreased (453)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Hepatic function abnormal Risk?
ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA